Meta AnalysisID 3734

香芹酚和百里香酚的抗肿瘤活性:一项系统评价[暂定标题]

CRD42020176736

Do carvacrol and thymol have any anti-tumor effect on cancer cells and in animal experiments? Context and rationale Cancer is one of the main public health problems in the world and appears among the top four causes of p

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
3734
Evidence Id
12292
Core Evidence Id
12292
Source Meta Analysis Id
3695
Herb2 Meta Analysis Id
HBMA003695
Crd Id
CRD42020176736
Title
Antitumor activity of carvacrol and thymol - a systematic review [provisional title]
Review Question
Do carvacrol and thymol have any anti-tumor effect on cancer cells and in animal experiments? Context and rationale Cancer is one of the main public health problems in the world and appears among the top four causes of premature death (before age 70) in most countries. Its incidence and mortality are increasing worldwide due to aging and population growth, as well as changes in the distribution and prevalence of socioeconomic cancer risk factors (INCA, 2020). Currently, cancer treatment includes chemotherapy, radiation therapy and / or surgical procedures, which in turn have many side effects. Therefore, active products derived from medicinal plants have been used as a safe and effective alternative, which can also be used for the prevention and treatment of certain types of cancer. In this context, the objective of this review is to systematically review whether carvacrol and thymol, natural components of the essential oils of thyme, oregano, rosemary and laurel, are promising alternatives for anticancer agents through surveys of in-vivo and in- vitro.
Study Type Included
Inclusion criteria: Experimental studies (pre-clinical in vitro or in vivo) Exclusion criteria: Clinical studies
Condition Being Studied
Participant
Animal
Inclusion criteria: Laboratory animal with disease (Male Swiss mice, Female Swiss mice, Male Sprague-Dawley rats, Adult male CF No 1 mice, Male Strain CF-1 mice, Male ICR mice, Male Lewis rats, Male Wistar rats, Male BALB/c mice) and in-vitro studies for antitumor effect (cell viability, apoptosis). Exclusion criteria: Animals with other associated diseases, Experimental animals that used anti-inflammatory drugs
Human Disease Modelled
Cancer
Intervention
Inclusion criteria: Monoterpenes (carvacrol and thymol) independently of timing of treatment or obtaining Exclusion criteria: Studies that evaluated essential oils in general, without studying carvacrol and/or thymol separately.
Comparator Control
Inclusion criteria: No treatment or placebo Exclusion criteria: None
Main Outcome
Outcome Measure
Inclusion criteria: Behavioral, biochemical, molecular and histology Exclusion criteria: Effects not directly related to cancer involvement: Antibacterial effects, anti-inflammatory effects, antioxidants, antiangiogenics, among others
Additional Outcome
Study Method
Keyword
Animals; Monoterpenes; Thymol; carvacrol
Contact
Laeza Alves Sampaio [email protected]
Organisational Affiliation
Universidade Federal de Sergipe http://www.ufs.br/
Funding Source
None Grant number(s) None
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Pre-clinical animal intervention review
Language
English
Country
Brazil
Review Stage
Review Ongoing
First Submission Date
2020-04-06
Registration Date
2020-05-22
Anticipated Start Date
2020-05-30
Anticipated Completion Date
2020-12-07
Title Cn
香芹酚和百里香酚的抗肿瘤活性:一项系统评价[暂定标题]
Title En
Antitumor activity of carvacrol and thymol - a systematic review [provisional title]
Bilingual Status
complete